PMID- 26621454 OWN - NLM STAT- MEDLINE DCOM- 20160523 LR - 20181113 IS - 1540-9538 (Electronic) IS - 0022-1007 (Print) IS - 0022-1007 (Linking) VI - 212 IP - 13 DP - 2015 Dec 14 TI - Melanocyte antigen triggers autoimmunity in human psoriasis. PG - 2203-12 LID - 10.1084/jem.20151093 [doi] AB - Psoriasis vulgaris is a common T cell-mediated inflammatory skin disease with a suspected autoimmune pathogenesis. The human leukocyte antigen (HLA) class I allele, HLA-C*06:02, is the main psoriasis risk gene. Epidermal CD8(+) T cells are essential for psoriasis development. Functional implications of HLA-C*06:02 and mechanisms of lesional T cell activation in psoriasis, however, remained elusive. Here we identify melanocytes as skin-specific target cells of an HLA-C*06:02-restricted psoriatic T cell response. We found that a Valpha3S1/Vbeta13S1 T cell receptor (TCR), which we had reconstituted from an epidermal CD8(+) T cell clone of an HLA-C*06:02-positive psoriasis patient specifically recognizes HLA-C*06:02-positive melanocytes. Through peptide library screening, we identified ADAMTS-like protein 5 (ADAMTSL5) as an HLA-C*06:02-presented melanocytic autoantigen of the Valpha3S1/Vbeta13S1 TCR. Consistent with the Valpha3S1/Vbeta13S1-TCR reactivity, we observed numerous CD8(+) T cells in psoriasis lesions attacking melanocytes, the only epidermal cells expressing ADAMTSL5. Furthermore, ADAMTSL5 stimulation induced the psoriasis signature cytokine, IL-17A, in CD8(+) T cells from psoriasis patients only, supporting a role as psoriatic autoantigen. This unbiased analysis of a TCR obtained directly from tissue-infiltrating CD8(+) T cells reveals that in psoriasis HLA-C*06:02 directs an autoimmune response against melanocytes through autoantigen presentation. We propose that HLA-C*06:02 may predispose to psoriasis via this newly identified autoimmune pathway. CI - (c) 2015 Arakawa et al. FAU - Arakawa, Akiko AU - Arakawa A AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Siewert, Katherina AU - Siewert K AD - Institute of Clinical Neuroimmunology, Ludwig-Maximilian-University, D-82152 Planegg-Martinsried, Germany. FAU - Stohr, Julia AU - Stohr J AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Besgen, Petra AU - Besgen P AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Kim, Song-Min AU - Kim SM AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Ruhl, Geraldine AU - Ruhl G AD - Institute of Clinical Neuroimmunology, Ludwig-Maximilian-University, D-82152 Planegg-Martinsried, Germany. FAU - Nickel, Jens AU - Nickel J AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Vollmer, Sigrid AU - Vollmer S AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Thomas, Peter AU - Thomas P AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Krebs, Stefan AU - Krebs S AD - Gene Center Munich, Ludwig-Maximilian-University, D-81377 Munich, Germany. FAU - Pinkert, Stefan AU - Pinkert S AD - German Cancer Research Center, D-69120 Heidelberg, Germany. FAU - Spannagl, Michael AU - Spannagl M AD - Laboratory of Immunogenetics and Molecular Diagnostics, Ludwig-Maximilian-University, D-81377 Munich, Germany. FAU - Held, Kathrin AU - Held K AD - Institute of Clinical Neuroimmunology, Ludwig-Maximilian-University, D-82152 Planegg-Martinsried, Germany. FAU - Kammerbauer, Claudia AU - Kammerbauer C AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Besch, Robert AU - Besch R AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany. FAU - Dornmair, Klaus AU - Dornmair K AD - Institute of Clinical Neuroimmunology, Ludwig-Maximilian-University, D-82152 Planegg-Martinsried, Germany. FAU - Prinz, Jorg C AU - Prinz JC AD - Department of Dermatology, Ludwig-Maximilian-University, D-80337 Munich, Germany joerg.prinz@med.uni-muenchen.de. LA - eng SI - PIR/MIM177900 SI - RefSeq/NP_998769 SI - SWISSPROT/A6NK89 SI - SWISSPROT/A6NLJ0 SI - SWISSPROT/Q14CZ8 SI - SWISSPROT/Q8WUY1 SI - SWISSPROT/Q9NR48 PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151130 PL - United States TA - J Exp Med JT - The Journal of experimental medicine JID - 2985109R RN - 0 (Autoantigens) RN - 0 (Epitopes) RN - 0 (HLA-C Antigens) RN - 0 (Peptides) RN - 0 (Receptors, Antigen, T-Cell, alpha-beta) RN - EC 3.4.24.- (ADAM Proteins) RN - EC 3.4.24.- (ADAMTS Proteins) RN - EC 3.4.24.- (ADAMTSL5 protein, human) SB - IM CIN - J Exp Med. 2015 Dec 14;212(13):2186. PMID: 26666753 CIN - Pigment Cell Melanoma Res. 2016 May;29(3):261-3. PMID: 26929278 MH - ADAM Proteins/metabolism MH - ADAMTS Proteins MH - Adult MH - Amino Acid Sequence MH - Autoantigens/*immunology MH - Autoimmunity/*immunology MH - CD8-Positive T-Lymphocytes/immunology MH - Cell Line MH - Epidermis/metabolism/pathology MH - Epitopes/chemistry/immunology MH - Female MH - HLA-C Antigens/immunology MH - Humans MH - Male MH - Melanocytes/*metabolism MH - Molecular Sequence Data MH - Peptides/chemistry MH - Psoriasis/*immunology MH - Receptors, Antigen, T-Cell, alpha-beta/metabolism PMC - PMC4689169 EDAT- 2015/12/02 06:00 MHDA- 2016/05/24 06:00 PMCR- 2016/06/14 CRDT- 2015/12/02 06:00 PHST- 2015/07/02 00:00 [received] PHST- 2015/11/04 00:00 [accepted] PHST- 2015/12/02 06:00 [entrez] PHST- 2015/12/02 06:00 [pubmed] PHST- 2016/05/24 06:00 [medline] PHST- 2016/06/14 00:00 [pmc-release] AID - jem.20151093 [pii] AID - 20151093 [pii] AID - 10.1084/jem.20151093 [doi] PST - ppublish SO - J Exp Med. 2015 Dec 14;212(13):2203-12. doi: 10.1084/jem.20151093. Epub 2015 Nov 30.